Free CME from PeerView


Oncology CME

Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Changing Times for Hemophilia: Exploring Evidence With Novel and Emerging Nonfactor Therapies
Steven W. Pipe, MD
December 30, 2022
Credits: 0.25 CME / MOC
Medical Learning Institute, Inc.
New Evidence Now for Targeted Therapy in TGCT
Prof. Hans Gelderblom, MD
December 23, 2022
Credits: 1.25 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Critical Conversations on Venous Thromboembolism: A MasterClass Series on DVT and PE
Alexander (Ander) T. Cohen, MBBS, MSc, MD, FRACP, FESC, FRCP
December 16, 2022
Credits: 1.5 CME / MOC
PSU, Penn State University
The Rising Tide of CAR-T in Lymphoma: Guidance on Leveraging Cellular Therapy to Improve Outcomes Across the Spectrum of Care
Jason Westin, MD, MS, FACP
December 09, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
The Winning Way With BTK Inhibitors in CLL: Evidence-Informed Choices on Treatment Selection, Safety, and Therapeutic Sequencing
John C. Byrd, MD
December 09, 2022
Credits: 2.0 CME / MOC
Medical Learning Institute, Inc.
The Road to Remission in Multiple Myeloma: Expert Guidance on Using BCMA-Targeted Options to Enhance Clinical Outcomes
Nikhil C. Munshi, MD
December 09, 2022
Credits: 1.5 CME / MOC
PSU, Penn State University
The Future is Now in MDS: Integrating Innovative, Risk-Adapted Therapies Into Patient Management
Guillermo Garcia-Manero, MD
December 09, 2022
Credits: 2.0 CME / MOC
PSU, Penn State University
Fine-Tuning the Wave of Innovation in CLL: Personalized Models for Upfront and Sequential Care With Groundbreaking Treatment
Prof. John G. Gribben, MD, DSc
December 09, 2022
Credits: 1.5 CME / MOC
Penn State College of Medicine
Real-World, Real Innovation in DLBCL: Perspectives on Integrating Novel Antibody Platforms Into Patient Care
Grzegorz (Greg) Nowakowski, MD
December 09, 2022
Credits: 1.25 CME
Medical Learning Institute, Inc.
Demystifying Cold Agglutinin Disease: A Visual Exploration of Mechanism, Diagnosis, and the Role of Complement Inhibition in Addressing Unmet Needs
Sigbjørn Berentsen, MD, PhD / Ilene C. Weitz, MD
December 09, 2022
Credits: 1.5 CME / MOC
Penn State College of Medicine
Maintaining “Intensity” for Better Outcomes in AML: Guidance on Modern, Intensive Upfront Platforms in Challenging Patient Populations
Gail J. Roboz, MD
December 09, 2022
Credits: 1.5 CME / MOC
Penn State College of Medicine
The Sequel to the Targeted Therapy Era in CML: Guidance on Integrating Novel Options Into Cohesive Sequential Care
Vivian G. Oehler, MD
December 09, 2022
Credits: 1.5 CME / MOC
PSU, Penn State University
Fixing the Target on Aggressive Lymphoma: Guidance on the Next Phase of Integrating Targeted Agents Into MCL and DLBCL Management
Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD
December 09, 2022
Credits: 2.0 CME / MOC
PVI, PeerView Institute for Medical Education
Clarifying the Complexities of the Expanding Treatment Options for Advanced- and Early-Stage HR+/HER2- Breast Cancer
Erika Hamilton, MD
December 07, 2022
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
On the Cusp of Change: Modernizing the Treatment of Desmoid Tumors With Novel Gamma Secretase Inhibitors
Bernd Kasper, MD, PhD
November 30, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Case by Case: Maximizing Personalized Approaches to Prostate Cancer
Rana R. McKay, MD / Alicia K. Morgans, MD, MPH
November 30, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Personalizing Bladder Cancer Care in the Modern Therapeutic Era: One Size No Longer Fits All
Petros Grivas, MD, PhD
November 30, 2022
Credits: 1.5 CME
PVI, PeerView Institute for Medical Education
Setting Our Sights on Improved Outcomes in Glioblastoma: State-of-the-Art Care With Tumor Treating Fields and Other Innovative Approaches
Steven Brem, MD
November 18, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal: Advancing Patient-Centered Care to Make the Most of Modern Targeted Treatments
Professor Peter Schmid, FRCP, MD, PhD
November 16, 2022
Credits: 1.0 CME / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Getting to the Heart of Personalized ADT for Advanced Prostate Cancer: Are You Able to Leverage New Data and Therapy Options to Maximize Cardiovascular Safety and Treatment-Related Outcomes?
Daniel J. George, MD
November 15, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Don’t Miss the Rare When Diagnosing and Treating Autoimmune Hemolytic Anemia: Focus on CAD
Morie A. Gertz, MD
November 09, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
It Takes a Team for HCC: Improving Outcomes Through Multidisciplinary Collaboration & Modern Therapeutics
Amit Singal, MD, MS
November 05, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Updating Our Cardio-Oncology Skills in the Cancer Immunotherapy Era: Team-Based Strategies for Risk Assessment, Diagnosis, and Management of Myocarditis and Other Cardiac Immune-Related Adverse Events
Javid Moslehi, MD
November 05, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
RCC Clinical Consults: Making Difficult Treatment Decisions at the Intersection of the Data and the Real World
Sumanta Kumar Pal, MD, FASCO
November 04, 2022
Credits: 1.0 CME
Medical Learning Institute, Inc.
Creating a Roadmap for Modern Prostate Cancer Treatment: How to Use the Most Recent Evidence on Novel Therapeutic Strategies and Shared Decision-Making to Personalize Patient Care
Alicia K. Morgans, MD, MPH
October 31, 2022
Credits: 0.75 CME / MOC / NCPD / IPCE
PVI, PeerView Institute for Medical Education
Clinical Conundrums in Pretreated Metastatic Urothelial Carcinoma: Improving Patient Outcomes With Novel Antibody-Drug Conjugates
Scott T. Tagawa, MD, MS, FACP
October 27, 2022
Credits: 1.5 CME
PVI, PeerView Institute for Medical Education
Harnessing Novel Synergies With Tumor Treating Fields: Insights on Improving Survival With Multimodal Care in Aggressive Tumors
Erik P. Sulman, MD, PhD
October 24, 2022
Credits: 1.0 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Breaking Down Barriers to Treatment Adherence and Persistence in HR+/HER2- Early Breast Cancer
Sara M. Tolaney, MD, MPH
October 17, 2022
Credits: 1.0 CME / CC
PVI, PeerView Institute for Medical Education
The Eye-Deal Connection in Multiple Myeloma: Establishing Ophthalmology-Oncology Relationships to Overcome Ocular Toxicity
Praneetha Thulasi, MD / Jonathan L. Kaufman, MD
October 01, 2022
Credits: 0.75 CME / MOC
PVI, PeerView Institute for Medical Education
Extending Survival and Setting Our Sights on Cure in Resectable NSCLC: Getting the Details of Perioperative Immunotherapy Right
Nasser Altorki, MD
September 30, 2022

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView